Why the study?
Does polypharmacy and potentially inappropriate medication use increase chemotherapy-related toxicity and hospitalization in older adults with cancer undergoing chemotherapy?
Does polypharmacy and potentially inappropriate medication use increase chemotherapy-related toxicity and hospitalization in older adults with cancer undergoing chemotherapy?
In older adults with cancer undergoing chemotherapy, polypharmacy and potentially inappropriate medication use were not associated with increased toxicity or hospitalization.
Should not yet change medication management in older adults on chemotherapy; leaves open causal effects of deprescribing in randomized trials.
Polypharmacy and PIM use were common but were not associated with chemotherapy-related toxicity or hospitalization in older adults with cancer.
No takes yet. Share an insight, caveat, or question.
Maggiore et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: